Clopidogrel News
Experts Offer Clarity on Confusion Surrounding Stents - Washington Post
For that reason, the FDA recommends that patients who receive drug-eluting stents be placed on dual anti-platelet therapy -- typically Plavix (clopidogrel) ...
Restricted or delayed access to clopidogrel drives deaths poststenting - TheHeart.Org
Montreal, QC - Insurance drug plans that restrict or delay access to clopidogrel poststenting may significantly increase the risk of mortality, ...
Lipitor's Superior Effect on Mortality Over Sales-Leading Plavix ... - PR Newswire (press release)
Physicians in the United States and Europe acknowledge that cost is a significant obstacle to prescribing clopidogrel. Additionally, with clinical trial ...
Patients at risk of adverse events within 3 months after stopping ... - News-Medical.net
Patients who receive the anti-platelet medication clopidogrel following an acute coronary syndrome (such as heart attack) appear to be at greater risk of a ...
Cogentus Pharmaceuticals Names Scientific Steering Committee for ... - FOXBusiness
The ongoing COGENT program will evaluate the efficacy and safety of Cogentus's lead product, CGT-2168, which combines the antiplatelet medicine clopidogrel ...
Stopping Plavix Doubles Risk of Heart Attack or Death for 90 Days ... - Angioplasty.Org
The increased risk occurred whether or not patients had received stents and was similar for all durations of clopidogrel therapy studied: from less than six ...
Risk of Stopping Clopidogrel After Heart Attack, Cannabis and Gum ... - Insider Medicine
... at particularly high risk of developing another heart attack or dying in the 30 days after they stop taking the anti-clotting medication clopidogrel. ...
Rebound effect on stopping clopidogrel - TheHeart.Org
Denver, CO - A clustering of adverse events in the initial 90 days after stopping clopidogrel among both medically treated and PCI-treated patients with ACS ...
When Clopidogrel Stops, ACS Patients Have 90-Day Spike in MI and Death - MedPage Today
5 -- Acute coronary syndrome patients who stop clopidogrel (Plavix) therapy are at risk for acute myocardial infarction or death, particularly for the first ...
Patients undergoing cerebrovascular stent placement respond poorly ... - HULIQ
Clopidogrel (Plavix) and aspirin are medications routinely prescribed for 1-3 months following cerebrovascular stent placement to combat the risk of blood ...
Clopidogrel RSS Feed